Literature DB >> 32198752

Circulating and tissue microRNAs as a potential diagnostic biomarker in patients with thrombotic events.

Reza Jafarzadeh-Esfehani1, Seyed Mostafa Parizadeh2,3, Amirsaeed Sabeti Aghabozorgi4, Negar Yavari3, Ariane Sadr-Nabavi1, Seyed Alireza Parizadeh2, Maryam Ghandehari2,3, Afsane Javanbakht2,3, Afsaneh Rezaei-Kalat5, Seyed Mahdi Hassanian2, Mohammad Vojdanparast6, Gordon A Ferns7, Majid Khazaei2,3, Amir Avan2,3.   

Abstract

Venous and arterial thrombosis are conditions that have a considerable burden if left untreated. The hypoxia-induced by the occluded vessel can disrupt the circulation of any organ, the cornerstone of treating thrombosis is rapid diagnosis and appropriate treatment. Diagnosis of thrombosis may be made by using laboratory tests or imaging techniques in individuals who have clinical manifestations of a thrombotic event. The use of serum micro ribonucleic acids (RNAs) has recently been applied to the diagnosis of thrombosis. These small RNA molecules are emerging as new diagnostic markers but have had very limited applications in vascular disease. Most of the articles provided various microRNAs with different levels of accuracy. However, there remains a lack of an appropriate panel of the most specific microRNA in the literature. The purpose of the present review was to summarize the existing data on the use of microRNAs as a diagnostic biomarker for venous thrombosis.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarker; diagnosis; microRNA; prognosis; thromboembolism; thrombosis

Year:  2020        PMID: 32198752     DOI: 10.1002/jcp.29639

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis.

Authors:  Ya Zhou; Zhihao Yao; Linjie Zhu; Yong Tang; Jie Chen; Jianming Wu
Journal:  Front Pharmacol       Date:  2021-02-02       Impact factor: 5.810

2.  miR-30b-5p Downregulation as a Predictive Biomarker of Coronary In-Stent Restenosis.

Authors:  Encarnación Gutierrez-Carretero; Isabel Mayoral-González; Francisco Jesús Morón; Mónica Fernández-Quero; Alejandro Domínguez-Rodríguez; Antonio Ordóñez; Tarik Smani
Journal:  Biomedicines       Date:  2021-03-30

3.  MiR-124 and miR-506 are involved in the decline of protein C in children with extra-hepatic portal vein obstruction.

Authors:  Jin-Shan Zhang; Long Li
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

4.  Nomogram for Predicting Deep Venous Thrombosis in Lower Extremity Fractures.

Authors:  Ze Lin; Bobin Mi; Xuehan Liu; Adriana C Panayi; Yuan Xiong; Hang Xue; Wu Zhou; Faqi Cao; Jing Liu; Liangcong Hu; Yiqiang Hu; Lang Chen; Chenchen Yan; Xudong Xie; Junfei Guo; Zhiyong Hou; Yun Sun; Yingze Zhang; Yu Hu; Guohui Liu
Journal:  Biomed Res Int       Date:  2021-06-22       Impact factor: 3.411

5.  miR-4284 Promotes Cell Proliferation, Migration, and Invasion in Non-Small Cell Lung Cancer Cells and is Associated with Postoperative Prognosis.

Authors:  Hanbing Yang; Wenjing Zhang; Qingxia Luan; Yanchao Liu
Journal:  Cancer Manag Res       Date:  2021-07-28       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.